Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 20;e13437.
doi: 10.1111/dth.13437. Online ahead of print.

Doxycycline, a Widely Used Antibiotic in Dermatology With a Possible Anti-Inflammatory Action Against IL-6 in COVID-19 Outbreak

Affiliations
Free PMC article

Doxycycline, a Widely Used Antibiotic in Dermatology With a Possible Anti-Inflammatory Action Against IL-6 in COVID-19 Outbreak

Claudio Conforti et al. Dermatol Ther. .
Free PMC article

Similar articles

See all similar articles

Cited by 1 article

References

    1. Conforti C, Cannavò SP, Jafferany M, et al. Coronavirus disease 2019 (COVID‐19): facts and controversies. Dermatol Ther. 2020;e13366 10.1111/dth.13366. [Epub ahead of print]. - DOI - PubMed
    1. Rudnicka L, Gupta M, Kassir M, et al. Priorities for global health community in COVID‐19 pandemic. Dermatol Ther. 2020;e13361 10.1111/dth.13361. [Epub ahead of print]. - DOI - PMC - PubMed
    1. Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020;e13298 10.1111/dth.13298 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH across speciality collaboration, UK. COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033‐1034. 10.1016/S0140-6736(20)30628-0. - DOI - PMC - PubMed
    1. McGonagle D, Sharif K, O'Regan A, Bridgewood C. Interleukin‐6 use in COVID‐19 pneumonia related macrophage activation syndrome. Autoimmun Rev. 2020;102537 10.1016/j.autrev.2020.102537 [Epub ahead of print]. - DOI - PMC - PubMed
Feedback